Kyung Hee Medical Center Signs Agreement for Industrial and Medical Cannabis Research and Development
[Asia Economy Reporter Kim Young-won] Kyung Hee Medical Center announced on the 21st that it held a signing ceremony on the 20th with Hemp & Al Bio and GIBITA to advance the domestic healthcare industry using industrial and medical hemp.
The signing ceremony was attended by Kim Sung-wan, Director of Kyung Hee Medical Center; Oh Joo-hyung, Director of Kyung Hee University Hospital; Yoon Kyung-sik, Director of Kyung Hee Medical Science Research Institute; Kim Young-min, CEO of Hemp & Al Bio; and Lee Gil-yeon, CEO of GIBITA (Director of the Clinical Center at Kyung Hee Medical Center Humanitas Cancer Hospital).
Currently, medical hemp, which is used for medical purposes in many countries, is gaining attention for its applications such as new drugs utilizing the efficacy of its main component Cannabinoid (CBD). However, in Korea, it is regulated as a narcotic, resulting in limited development of pharmaceuticals and application in the healthcare industry. Although the use of medical hemp has been partially permitted under the revised "Narcotics Control Act" of 2018, there is an evaluation that research on its medical usefulness and functions is insufficient domestically.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051414165763158_1778735817.jpg)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- Experts Shocked by Record Numbers: "Just the Tip of the Iceberg" — The Identity Behind the 90% Dominating Teens [Chuiyakgukga]⑨
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- "Bought for a Special Price, but Cheaper Today"... Online Malls Caught Inflating Discount Rates by Raising Regular Prices
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
Through this agreement, Kyung Hee Medical Center plans to collaborate with Hemp & Al Bio and GIBITA to conduct correlation analyses on the efficacy and therapeutic effects of legally cultivated, processed, and produced hemp. They will be responsible for providing medical and technical support regarding the usefulness and functions of healthcare products using industrial and medical hemp.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Cheaper Than Mychew, but Nowhere to Be Found... Fears of a 'Pediatric Medical Crisis' as Drug Makers Halt Production [Why&Next]](https://cwcontent.asiae.co.kr/asiaresize/307/2026051910065268365_1779152813.jpg)
